<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35900868</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>18</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e161908</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI161908</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons. Mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT), which catalyzes the first step in the de novo synthesis of sphingolipids (SLs), cause childhood-onset ALS. SPTLC1-ALS variants map to a transmembrane domain that interacts with ORMDL proteins, negative regulators of SPT activity. We show that ORMDL binding to the holoenzyme complex is impaired in cells expressing pathogenic SPTLC1-ALS alleles, resulting in increased SL synthesis and a distinct lipid signature. C-terminal SPTLC1 variants cause peripheral hereditary sensory and autonomic neuropathy type 1 (HSAN1) due to the synthesis of 1-deoxysphingolipids (1-deoxySLs) that form when SPT metabolizes L-alanine instead of L-serine. Limiting L-serine availability in SPTLC1-ALS-expressing cells increased 1-deoxySL and shifted the SL profile from an ALS to an HSAN1-like signature. This effect was corroborated in an SPTLC1-ALS pedigree in which the index patient uniquely presented with an HSAN1 phenotype, increased 1-deoxySL levels, and an L-serine deficiency. These data demonstrate how pathogenic variants in different domains of SPTLC1 give rise to distinct clinical presentations that are nonetheless modifiable by substrate availability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lone</LastName><ForeName>Museer A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aaltonen</LastName><ForeName>Mari J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zidell</LastName><ForeName>Aliza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Genetic and Genomic Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedro</LastName><ForeName>Helio F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Center for Genetic and Genomic Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genetic and Genomic Medicine, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales Saute</LastName><ForeName>Jonas A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Medical Genetics Division and Neurology Division, Hospital de Cl&#xed;nicas de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Medicine, Medical Sciences, and Internal Medicine Department, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shalett</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohassel</LastName><ForeName>Payam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;nnemann</LastName><ForeName>Carsten G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoubridge</LastName><ForeName>Eric A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornemann</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K22 NS104135</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>173437</GrantID><Agency>Canadian Institute of Health Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013107">Sphingolipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="C487784">SPTLC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="D051102">Serine C-Palmitoyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009477" MajorTopicYN="Y">Hereditary Sensory and Autonomic Neuropathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051102" MajorTopicYN="N">Serine C-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013107" MajorTopicYN="N">Sphingolipids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Carbohydrate metabolism</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">Neuroscience</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35900868</ArticleId><ArticleId IdType="pmc">PMC9479574</ArticleId><ArticleId IdType="doi">10.1172/JCI161908</ArticleId><ArticleId IdType="pii">161908</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsai G, et al. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans. J Clin Invest. 2019;129(3):1229&#x2013;1239. doi: 10.1172/JCI124159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI124159</ArticleId><ArticleId IdType="pmc">PMC6391115</ArticleId><ArticleId IdType="pubmed">30620338</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo AC, et al. Amyotrophic lateral sclerosis: a focus on disease progression. Biomed Res Int. 2014;2014:925101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137497</ArticleId><ArticleId IdType="pubmed">25157374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P, et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat Med. 2021;27(1):1197&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone MA, et al. SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS [preprint]. Posted on medRxiv February 08, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.07.22269609</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis. JAMA Neurol. 2021;78(10):1236&#x2013;1248. doi: 10.1001/jamaneurol.2021.2598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2598</ArticleId><ArticleId IdType="pmc">PMC8406220</ArticleId><ArticleId IdType="pubmed">34459874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone MA, et al. 1-Deoxysphingolipids. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(4):512&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625374</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichler FS, et al. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J Neurosci. 2009;29(46):14646&#x2013;14651. doi: 10.1523/JNEUROSCI.2536-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2536-09.2009</ArticleId><ArticleId IdType="pmc">PMC3849752</ArticleId><ArticleId IdType="pubmed">19923297</ArticleId></ArticleIdList></Reference><Reference><Citation>Penno A, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010;285(15):11178&#x2013;11187. doi: 10.1074/jbc.M109.092973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.092973</ArticleId><ArticleId IdType="pmc">PMC2856995</ArticleId><ArticleId IdType="pubmed">20097765</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlden H, et al. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I) Brain. 2006;129(pt 2):411&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364956</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M. Hereditary sensory and autonomic neuropathies. Handb Clin Neurol. 2013;115:893&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">23931820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejaoui K, et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet. 2001;27(3):261&#x2013;262. doi: 10.1038/85817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/85817</ArticleId><ArticleId IdType="pubmed">11242106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawkins JL, et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001;27(3):309&#x2013;312. doi: 10.1038/85879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/85879</ArticleId><ArticleId IdType="pubmed">11242114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode H, et al. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship. Hum Mol Genet. 2016;25(5):853&#x2013;865. doi: 10.1093/hmg/ddv611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv611</ArticleId><ArticleId IdType="pubmed">26681808</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaltonen MJ, et al. Serine palmitoyltransferase assembles at ER-mitochondria contact sites. Life Sci Alliance. 2022;5(2):e202101278. doi: 10.26508/lsa.202101278.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101278</ArticleId><ArticleId IdType="pmc">PMC8605320</ArticleId><ArticleId IdType="pubmed">34785538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Structural insights into the regulation of human serine palmitoyltransferase complexes. Nat Struct Mol Biol. 2021;28(3):240&#x2013;248. doi: 10.1038/s41594-020-00551-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00551-9</ArticleId><ArticleId IdType="pubmed">33558761</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, et al. Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex. Nat Struct Mol Biol. 2021;28(3):249&#x2013;257. doi: 10.1038/s41594-020-00553-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00553-7</ArticleId><ArticleId IdType="pubmed">33558762</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G, et al. The ORMs interact with transmembrane domain 1 of Lcb1 and regulate serine palmitoyltransferase oligomerization, activity and localization. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(3):245&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373489</ArticleId><ArticleId IdType="pubmed">30529276</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslow DK, et al. Orm family proteins mediate sphingolipid homeostasis. Nature. 2010;463(7284):1048&#x2013;1053. doi: 10.1038/nature08787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08787</ArticleId><ArticleId IdType="pmc">PMC2877384</ArticleId><ArticleId IdType="pubmed">20182505</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, et al. Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control. Proc Natl Acad Sci U S A. 2010;107(13):5851&#x2013;5856. doi: 10.1073/pnas.0911617107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911617107</ArticleId><ArticleId IdType="pmc">PMC2851911</ArticleId><ArticleId IdType="pubmed">20212121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone MA, et al. Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases. Proc Natl Acad Sci U S A. 2020;117(27):15591&#x2013;15598. doi: 10.1073/pnas.2002391117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002391117</ArticleId><ArticleId IdType="pmc">PMC7355037</ArticleId><ArticleId IdType="pubmed">32576697</ArticleId></ArticleIdList></Reference><Reference><Citation>Green CD, et al. CRISPR/Cas9 deletion of ORMDLs reveals complexity in sphingolipid metabolism. J Lipid Res. 2021;62:100082. doi: 10.1016/j.jlr.2021.100082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100082</ArticleId><ArticleId IdType="pmc">PMC8167824</ArticleId><ArticleId IdType="pubmed">33939982</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow DL, Wattenberg BW. Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. J Biol Chem. 2012;287(48):40198&#x2013;40204. doi: 10.1074/jbc.C112.404012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C112.404012</ArticleId><ArticleId IdType="pmc">PMC3504734</ArticleId><ArticleId IdType="pubmed">23066021</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DL, et al. The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: reconstitution of SPT regulation in isolated membranes. J Biol Chem. 2019;294(13):5146&#x2013;5156. doi: 10.1074/jbc.RA118.007291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007291</ArticleId><ArticleId IdType="pmc">PMC6442065</ArticleId><ArticleId IdType="pubmed">30700557</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M, et al. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype. Eur J Med Genet. 2013;56(5):266&#x2013;269. doi: 10.1016/j.ejmg.2013.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2013.02.002</ArticleId><ArticleId IdType="pmc">PMC3682180</ArticleId><ArticleId IdType="pubmed">23454272</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantner ML, et al. Serine and lipid metabolism in macular disease and peripheral neuropathy. N Engl J Med. 2019;381(15):1422&#x2013;1433. doi: 10.1056/NEJMoa1815111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1815111</ArticleId><ArticleId IdType="pmc">PMC7685488</ArticleId><ArticleId IdType="pubmed">31509666</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthusamy T, et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature. 2020;586(7831):790&#x2013;795. doi: 10.1038/s41586-020-2609-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2609-x</ArticleId><ArticleId IdType="pmc">PMC7606299</ArticleId><ArticleId IdType="pubmed">32788725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun YA, Obeid LM. Many ceramides. J Biol Chem. 2011;286(32):27855&#x2013;27862. doi: 10.1074/jbc.R111.254359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R111.254359</ArticleId><ArticleId IdType="pmc">PMC3151029</ArticleId><ArticleId IdType="pubmed">21693702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternes P, et al. Identification and characterization of a sphingolipid delta 4-desaturase family. J Biol Chem. 2002;277(28):25512&#x2013;25518. doi: 10.1074/jbc.M202947200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M202947200</ArticleId><ArticleId IdType="pubmed">11937514</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsai G, et al. FADS3 is a &#x394;14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome. J Biol Chem. 2019;295(7):1889&#x2013;1897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029104</ArticleId><ArticleId IdType="pubmed">31862735</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotthier A, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain. 2009;132(pt 10):2699&#x2013;2711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2759337</ArticleId><ArticleId IdType="pubmed">19651702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotthier A, et al. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I. Hum Mutat. 2011;32(6):E2211&#x2013;E2225. doi: 10.1002/humu.21481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21481</ArticleId><ArticleId IdType="pubmed">21618344</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh BC, et al. Early-onset severe hereditary sensory and autonomic neuropathy type 1 with S331F SPTLC1 mutation. Mol Med Rep. 2014;9(2):481&#x2013;486. doi: 10.3892/mmr.2013.1808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2013.1808</ArticleId><ArticleId IdType="pubmed">24247255</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonicka H, et al. A high-density human mitochondrial proximity interaction network. Cell Metab. 2020;32(3):479&#x2013;497. doi: 10.1016/j.cmet.2020.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.017</ArticleId><ArticleId IdType="pubmed">32877691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochmuller H, et al. Expression of the E6 and E7 genes of human papillomavirus (HPV16) extends the life span of human myoblasts. Exp Cell Res. 1999;248(1):186&#x2013;193. doi: 10.1006/excr.1999.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1999.4407</ArticleId><ArticleId IdType="pubmed">10094825</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurek N, et al. Reticulon short hairpin transmembrane domains are used to shape ER tubules. Traffic. 2011;12(1):28&#x2013;41. doi: 10.1111/j.1600-0854.2010.01134.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2010.01134.x</ArticleId><ArticleId IdType="pmc">PMC3005309</ArticleId><ArticleId IdType="pubmed">20955502</ArticleId></ArticleIdList></Reference><Reference><Citation>Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987;166(2):368&#x2013;379. doi: 10.1016/0003-2697(87)90587-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(87)90587-2</ArticleId><ArticleId IdType="pubmed">2449095</ArticleId></ArticleIdList></Reference><Reference><Citation>Leary SC. Blue native polyacrylamide gel electrophoresis: a powerful diagnostic tool for the detection of assembly defects in the enzyme complexes of oxidative phosphorylation. Methods Mol Biol. 2012;837:195&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">22215549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhakupova A, et al. ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase. FASEB J. 2016;30(12):4289&#x2013;4300. doi: 10.1096/fj.201600639R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600639R</ArticleId><ArticleId IdType="pubmed">27645259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J, et al. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinformatics. 2019;68(1):e86.</Citation><ArticleIdList><ArticleId IdType="pubmed">31756036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>